Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENACT-AMI: Autologous EPCs with eNOS in Acute Myocardial Infarction
NCT00936819Phase 2Active, not recruiting
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Jul 2013
- Primary completion
- Mar 2020
- Modality
- Gene Editing, Gene Silencing, Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of eNOS-transfected autologous endothelial progenitor cells, autologous endothelial progenitor cells in acute myocardial infarction (AMI), sponsored by Ottawa Hospital Research Institute. Started Jul 2013; status: active, not recruiting.
02
Drugs
eNOS-transfected autologous endothelial progenitor cellsautologous endothelial progenitor cells
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT00936819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00936819.